AY20 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Aytu Biopharma Inc

Watchlist Manager

Watchlist

Price: 3.279 EUR Market Closed

Market Cap: €18.3m

A	Aytu Biopharma Inc F:AY20	US
	Cobra Venture Corp XTSX:CBV	CA
	Fraport AG Frankfurt Airport Services Worldwide F:FRA	DE
B	Brookfield Business Corp NYSE:BBUC	US
	Ardelyx Inc NASDAQ:ARDX	US
R	RPMGlobal Holdings Ltd F:4Q3	AU
P	Palatin Technologies Inc F:PTNA	US
	Thule Group AB STO:THULE	SE

Profitability Summary

Aytu Biopharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

67%

Strong 3Y Average Gross Margin

67%

Gross Margin is Increasing

62% > 67%

Negative Operating Margin

-1%

Negative 3Y Average Operating Margin

-3%

Operating Margin is Increasing

-11% > -1%

Negative Net Margin

-39%

Negative 3Y Average Net Margin

-17%

Declining Net Margin

-16% > -39%

Negative Free Cash Flow Margin

-6%

Negative 3Y Average Free Cash Flow Margin

-2%

Declining Free Cash Flow Margin

-5% > -6%

Negative ROE

-109%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-3%

ROIC is Increasing

-12% > -1%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.